These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 23797530)

  • 1. [Periprocedual management of vitamin K antagonist's with low molecular weight heparins during invasive procedures--Consensus of experts].
    Watzke H; Metzler H; Weltermann A; Marschang P; Brodmann M; Lang W; Pabinger-Fasching I; Mahla E; Kozek-Langenecker S; Guschmann M; Huber K
    Wien Klin Wochenschr; 2013 Jul; 125(13-14):412-20. PubMed ID: 23797530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
    Douketis JD; Berger PB; Dunn AS; Jaffer AK; Spyropoulos AC; Becker RC; Ansell J
    Chest; 2008 Jun; 133(6 Suppl):299S-339S. PubMed ID: 18574269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcomes with unfractionated heparin or low-molecular-weight heparin as bridging therapy in patients on long-term oral anticoagulants: the REGIMEN registry.
    Spyropoulos AC; Turpie AG; Dunn AS; Spandorfer J; Douketis J; Jacobson A; Frost FJ;
    J Thromb Haemost; 2006 Jun; 4(6):1246-52. PubMed ID: 16706967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Periprocedural bridging therapy in patients receiving chronic oral anticoagulation therapy.
    Spyropoulos AC; Bauersachs RM; Omran H; Cohen M
    Curr Med Res Opin; 2006 Jun; 22(6):1109-22. PubMed ID: 16846544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients requiring interruption of long-term oral anticoagulant therapy: the use of fixed sub-therapeutic doses of low-molecular-weight heparin.
    Malato A; Saccullo G; Lo Coco L; Caramazza D; Abbene I; Pizzo G; Casuccio A; Siragusa S
    J Thromb Haemost; 2010 Jan; 8(1):107-13. PubMed ID: 19817996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-molecular-weight-heparins as periprocedural anticoagulation for patients on long-term warfarin therapy: a standardized bridging therapy protocol.
    Jaffer AK; Ahmed M; Brotman DJ; Bragg L; Seshadri N; Qadeer MA; Klein A
    J Thromb Thrombolysis; 2005 Aug; 20(1):11-6. PubMed ID: 16133889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The HAS-BLED score predicts bleedings during bridging of chronic oral anticoagulation. Results from the national multicentre BNK Online bRiDging REgistRy (BORDER).
    Omran H; Bauersachs R; Rübenacker S; Goss F; Hammerstingl C
    Thromb Haemost; 2012 Jul; 108(1):65-73. PubMed ID: 22534746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of venous thromboembolism and hemorrhage related safety studies of preoperative anticoagulation therapy in hip fracture patients undergoing surgical treatment: a case-control study.
    Liu Z; Han N; Xu H; Fu Z; Zhang D; Wang T; Jiang B
    BMC Musculoskelet Disord; 2016 Feb; 17():76. PubMed ID: 26873584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Periprocedural anticoagulation management of patients with nonvalvular atrial fibrillation.
    Wysokinski WE; McBane RD; Daniels PR; Litin SC; Hodge DO; Dowling NF; Heit JA
    Mayo Clin Proc; 2008 Jun; 83(6):639-45. PubMed ID: 18533080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practice of bridging anticoagulation: guideline adherence and risk factors for bleeding.
    Eijgenraam P; ten Cate H; ten Cate-Hoek AJ
    Neth J Med; 2014 Apr; 72(3):157-64. PubMed ID: 24846933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perioperative complications in patients on low-molecular-weight heparin bridging therapy.
    Breen DT; Chavalertsakul N; Paul E; Gruen RL; Serpell J
    ANZ J Surg; 2016 Mar; 86(3):167-72. PubMed ID: 23336820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The management of patients who require temporary reversal of vitamin K antagonists for surgery: a practical guide for clinicians.
    Mannucci C; Douketis JD
    Intern Emerg Med; 2006; 1(2):96-104. PubMed ID: 17111781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-month cumulative incidence of thromboembolism and bleeding after periprocedural anticoagulation management of arterial vascular bypass patients.
    Attaya H; Wysokinski WE; Bower T; Litin S; Daniels PR; Slusser J; Heit JA; McBane RD
    J Thromb Thrombolysis; 2013 Jan; 35(1):100-6. PubMed ID: 22843195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effectiveness of low-molecular-weight heparins versus other anticoagulants in major orthopedic surgery: a systematic review and meta-analysis.
    Sobieraj DM; Coleman CI; Tongbram V; Chen W; Colby J; Lee S; Kluger J; Makanji S; Ashaye A; White CM
    Pharmacotherapy; 2012 Sep; 32(9):799-808. PubMed ID: 22744711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies and outcomes of periprocedural bridging therapy with low-molecular-weight heparin in patients with mechanical heart valves.
    Schulman JM; Majeed A; Mattsson E; Schulman S; Holmström M; Ågren A
    J Thromb Thrombolysis; 2015 Nov; 40(4):430-6. PubMed ID: 25868460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Standardized low-molecular-weight heparin bridging regimen in outpatients on oral anticoagulants undergoing invasive procedure or surgery: an inception cohort management study.
    Pengo V; Cucchini U; Denas G; Erba N; Guazzaloca G; La Rosa L; De Micheli V; Testa S; Frontoni R; Prisco D; Nante G; Iliceto S;
    Circulation; 2009 Jun; 119(22):2920-7. PubMed ID: 19470892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronically anticoagulated patients who need surgery: can low-molecular-weight heparins really be used to "bridge" patients instead of intravenous unfractionated heparin?
    Jaff MR
    Catheter Cardiovasc Interv; 2009 Jul; 74 Suppl 1():S17-21. PubMed ID: 19213061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bridging with enoxaparin using a half-therapeutic dose regimen: safety and efficacy.
    Klamroth R; Gottstein S; Essers E; Landgraf H
    Vasa; 2010 Aug; 39(3):243-8. PubMed ID: 20737383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen.
    Douketis JD; Johnson JA; Turpie AG
    Arch Intern Med; 2004 Jun; 164(12):1319-26. PubMed ID: 15226166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.